Autonomic cardiovascular control during a novel pharmacologic alternative to ganglionic blockade

Clinical Pharmacology and Therapeutics

Volumn 83, Issue 5, 2008, Pages 692-701

  Wilkins, B W ^a   Hesse, C ^a   Charkoudian, N ^a   Nicholson, W T ^a   Sviggum, H P ^a   Moyer, T P ^a   Joyner, M J ^a   Eisenach, J H ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXMEDETOMIDINE; GLYCOPYRRONIUM BROMIDE; NITROPRUSSIDE SODIUM; NORADRENALIN; PHENYLEPHRINE; TRIMETAPHAN;

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE MEASUREMENT; DRUG DOSE REDUCTION; DRUG MECHANISM; FEMALE; GANGLION BLOCK; HEMODYNAMICS; HUMAN; HUMAN EXPERIMENT; MALE; NERVE CONDUCTION; NORMAL HUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL;

ADRENERGIC ALPHA-AGONISTS; ADULT; AUTONOMIC NERVE BLOCK; BAROREFLEX; CARDIAC OUTPUT; CARDIOVASCULAR SYSTEM; CATECHOLAMINES; DEXMEDETOMIDINE; FEMALE; GANGLIONIC BLOCKERS; GLYCOPYRROLATE; HEART RATE; HUMANS; MALE; MUSCARINIC ANTAGONISTS; PHENYLEPHRINE; SYMPATHETIC NERVOUS SYSTEM; TRIMETHAPHAN;

EID: 42349113660     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/sj.clpt.6100326     Document Type: Article

References (39)

1. McAllister, R.G. Jr. et al. Peripheral beta-receptor responsiveness in patients with essential hypertension. Arch. Intern. Med. 139, 879-881 (1979).
2. Bertel, O. et al. Decreased beta-adrenoreceptor responsiveness as related to age, blood pressure, and plasma catecholamines in patients with essential hypertension. Hypertension 2, 130-138 (1980).
3. Vestal, R.E., Wood, A.J. & Shand, D.G. Reduced beta-adrenoceptor sensitivity in the elderly. Clin. Pharmacol. Ther. 26, 181-186 (1979).
4. Robertson, D. et al. Increased vascular beta2-adrenoceptor responsiveness in autonomic dysfunction. J. Am. Coll. Cardiol. 3, 850-856 (1984).
5. Eisenach, J.H. et al. Arg16/Gly beta2-adrenergic receptor polymorphism alters the cardiac output response to isometric exercise. J. Appl. Physiol. 99, 1776-1781 (2005).
6. Eisenach, J.H. et al. The Arg16/Gly beta2-adrenergic receptor polymorphism is associated with altered cardiovascular responses to isometric exercise. Physiol. Genomics 16, 323-328 (2004).
7. Johnson, J.A., Burlew, B.S. & Stiles, R.N. Racial differences in betaadrenoceptor-mediated responsiveness. J. Cardiovasc. Pharmacol. 25, 90-96 (1995).
8. Shannon, J.R. et al. Uncoupling of the baroreflex by N(N)-cholinergic blockade in dissecting the components of cardiovascular regulation. Hypertension 32, 101-107 (1998).
9. Jones, P.P. et al. Baroreflex buffering is reduced with age in healthy men. Circulation 107, 1770-1774 (2003).
10. Christou, D.D., Jones, P.P. & Seals, D.R. Baroreflex buffering in sedentary and endurance exercise-trained healthy men. Hypertension 41, 1219-1222 (2003).
11. Diedrich, A. et al. The sympathetic nervous system in hypertension: assessment by blood pressure variability and ganglionic blockade. J. Hypertens. 21, 1677-1686 (2003).
12. Katragadda, S. et al. Neural mechanism of the pressor response to obstructive and nonobstructive apnea. J. Appl. Physiol. 83, 2048-2054 (1997).
13. Zhang, R., Crandall, C.G. & Levine, B.D. Cerebral hemodynamics during the Valsalva maneuver: insights from ganglionic blockade. Stroke 35, 843-847 (2004).
14. Jordan, J. et al. N(N)-nicotinic blockade as an acute human model of autonomic failure. Hypertension 31, 1178-1184 (1998).
15. Shytle, R.D. et al. Mecamylamine (Inversine): an old antihypertensive with new research directions. J. Hum. Hypertens. 16, 453-457 (2002).
16. Wilkins, B.W. et al. Alternative to ganglionic blockade with anticholinergic and alpha-2 receptor agents. Clin. Auton. Res. 17, 77-84 (2006).
17. Gamboa, A., Diedrich, A. & Biaggioni, I. Pharmacological probes to measure the importance of the autonomic nervous system. Clin. Auton. Res. 17, 65-68 (2007).
18. Klowden, A.J., Ivankovich, A.D. & Miletich, D.J. Ganglionic blocking drugs: general considerations and metabolism. Int. Anesthesiol. Clin. 16, 113-150 (1978).
19. Ebert, T.J. et al. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 93, 382-394 (2000).
20. Hsu, Y.W. et al. Dexmedetomidine pharmacodynamics: part I: crossover comparison of the respiratory effects of dexmedetomidine and remifentanil in healthy volunteers. Anesthesiology 101, 1066-1076 (2004).
21. Ford, G.A. & James, O.F. Effect of "autonomic blockade" on cardiac beta-adrenergic chronotropic responsiveness in healthy young, healthy elderly and endurance-trained elderly subjects. Clin. Sci. (Lond) 87, 297-302 (1994).
22. Korner, P.I., Tonkin, A.M. & Uther, J.B. Reflex and mechanical circulatory effects of graded Valsalva maneuvers in normal man. J. Appl. Physiol. 40, 434-440 (1976).
23. Talke, P., Lobo, E. & Brown, R. Systemically administered alpha2-agonist-induced peripheral vasoconstriction in humans. Anesthesiology 99, 65-70 (2003).
24. Dinenno, F.A. et al. Post-junctional alpha-adrenoceptors and basal limb vascular tone in healthy men. J. Physiol. 540(Part 3): 1103-1110 (2002).
25. Muszkat, M. et al. Alpha2-adrenergic receptor-induced vascular constriction in blacks and whites. Hypertension 43, 31-35 (2004).
26. Shibao, C. et al. Autonomic contribution to blood pressure and metabolism in obesity. Hypertension 49, 27-33 (2007).
27. Harioka, T. et al. Trimethaphan is a direct arterial vasodilator and an alpha-adrenoceptor antagonist. Anesth. Analg. 63, 290-296 (1984).
28. Tank, J. et al. Alpha-2 adrenergic transmission and human baroreflex regulation. Hypertension 43, 1035-1041 (2004).
29. Diedrich, A. et al. Modulation of QT interval during autonomic nervous system blockade in humans. Circulation 106, 2238-2243 (2002).
30. Minson, C.T. et al. Influence of the menstrual cycle on sympathetic activity, baroreflex sensitivity, and vascular transduction in young women. Circulation 101, 862-868 (2000).
31. Minson, C.T. et al. Sympathetic activity and baroreflex sensitivity in young women taking oral contraceptives. Circulation 102, 1473-1476 (2000).
32. Ebert, T.J. & Cowley, A.W. Jr. Baroreflex modulation of sympathetic outflow during physiological increases of vasopressin in humans. Am. J. Physiol. 262(Part 2): H1372-H1378 (1992).
33. Halliwill, J.R. et al. Augmented baroreflex heart rate gain after moderate-intensity, dynamic exercise. Am. J. Physiol. 270(Part 2): R420-R426 (1996).
34. Johnson, B.D. et al. Cardiac output during exercise by the open circuit acetylene washin method: comparison with direct Fick. J. Appl. Physiol. 88, 1650-1658 (2000).
35. Sündlof, G. & Wallin, B.G. Human muscle nerve sympathetic activity at rest. Relationship to blood pressure and age. J. Physiol. 274, 621-637 (1978).
36. Halliwill, J.R. Segregated signal averaging of sympathetic baroreflex responses in humans. J. Appl. Physiol. 88, 767-773 (2000).
37. Halliwill, J.R., Taylor, J.A. & Eckberg, D.L. Impaired sympathetic vascular regulation in humans after acute dynamic exercise. J. Physiol. 495(Part 1): 279-288 (1996).
38. Charkoudian, N. et al. Influences of hydration on post-exercise cardiovascular control in humans. J. Physiol. 552(Part 2): 635-644 (2003).
39. Charkoudian, N. et al. Interactions of plasma osmolality with arterial and central venous pressures in control of sympathetic activity and heart rate in humans. Am. J. Physiol. Heart Circ. Physiol. 289, H2456-H2460 (2005).